Evaluation of the Efficiency of Local Application of Bee Products in the Care of Diaper Dermatitis in Infants
1 other identifier
interventional
93
1 country
1
Brief Summary
The aim of this study was to evaluate the local application of bee products in the care of diaper dermatitis in infants.
- 1.H1: Barrier cream 1, consisting of a mixture of propolis, beeswax, queen bee larva and plants oil used in the care of diaper dermatitis, is more effective in recovering diaper dermatitis than barrier cream 2 containing zinc oxide.
- 2.H2: Barrier cream 1, consisting of a mixture of propolis, beeswax, queen bee larva and plants oil used in the care of diaper dermatitis, is more effective in recovering diaper dermatitis than olive oil.
- 3.H3: Diaper Dermatitis Severity Assessment Scale scores are lower in babies who use barrier cream 1, which consists of a mixture of propolis, beeswax, queen bee larva and plants oil, in the care of diaper dermatitis, compared to babies who use barrier cream 2, which contains zinc oxide.
- 4.H4: Diaper Dermatitis Severity Assessment Scale scores are lower in babies who use barrier cream 1, which consists of a mixture of propolis, beeswax, queen bee larva and plants oil, in the care of diaper dermatitis, than babies who use olive oil.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 24, 2022
CompletedFirst Submitted
Initial submission to the registry
November 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedJanuary 17, 2024
January 1, 2024
11 months
November 7, 2023
January 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Scale for Assessing the Severity of Uncomplicated Diaper Dermatitis in Infants
The score to be received from each item of the scale varies between "0-6". The highest and lowest scores that can be obtained from the items are 0-3 points in the "Severity of Erythema or Irritation" item, 0-1 point in the "Extent of Diaper Dermatitis" item, 0-1 point in the "Papules and Pustules" item, and 0-1 point in the "Light Skin" item. It is between 0-1 points. Low total scores from the scale indicate that the severity of diaper dermatitis is low, and high scores indicate that the severity of diaper dermatitis is high.
5 minutes
Study Arms (3)
Experimental: Experimental Group1
EXPERIMENTALBarrier cream group 1 consists of a mixture of propolis, beeswax, queen bee larva and plant oil
Experimental: Experimental Group2
EXPERIMENTALOlive oil group
Control Group
ACTIVE COMPARATORBarrier cream group 2 consists of zinc oxide
Interventions
In this study, the infant's first-degree diaper dermatitis was determined by the doctor or midwife using the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants. After first-degree diaper dermatitis was detected in the babies and their written consent was obtained, the parents of the babies were informed about the research before application and the parent-baby identification information form was filled out. Families were provided with education based on the ABCDE model. Mothers were informed that Barrier cream 1 would be used at each diaper change. Baby dermatitis was monitored face to face by the researcher on the 1st, 3rd and 5th days, and the scores were recorded on the observation form. Follow-up of those with a diaper dermatitis score of "0" was discontinued because full recovery was achieved.
In this study, the infant's first-degree diaper dermatitis was determined by the doctor or midwife using the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants. After first-degree diaper dermatitis was detected in the babies and their written consent was obtained, the parents of the babies were informed about the research before application and the parent-baby identification information form was filled out. Families were provided with education based on the ABCDE model. Mothers were informed that barrier cream 2 would be used at each diaper change. Baby dermatitis was monitored face to face by the researcher on the 1st, 3rd and 5th days, and the scores were recorded on the observation form. Follow-up of those with a diaper dermatitis score of "0" was discontinued because full recovery was achieved.
In this study, the infant's first-degree diaper dermatitis was determined by the doctor or midwife using the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants. After first-degree diaper dermatitis was detected in the babies and their written consent was obtained, the parents of the babies were informed about the research before application and the parent-baby identification information form was filled out. Families were provided with education based on the ABCDE model. Mothers were informed that olive oil would be used at each diaper change. Baby dermatitis was monitored face to face by the researcher on the 1st, 3rd and 5th days, and the scores were recorded on the observation form. Follow-up of those with a diaper dermatitis score of "0" was discontinued because full recovery was achieved.
Eligibility Criteria
You may qualify if:
- Infants aged 1-6 months registered at Family Health Centers No. 1, No. 2 and No. 3,
- Infants aged 1-6 months admitted to Kumluca State Hospital's Pediatric Outpatient Clinic,
- Infants with grade one diaper dermatitis according to the Uncomplicated Diaper Dermatitis in Infants Severity Rating Scale,
- Breastfed babies,
- Babies without antibiotics,
- Families who do not regularly use protective barrier cream/oil for diaper dermatitis care,
- Babies who have not started supplementary food,
- Babies with no other dermatologic or allergic skin conditions,
- Families who agreed to participate in the study were included.
You may not qualify if:
- Babies who are not registered to the Family Health Centers where the research was conducted,
- Newborns and babies older than 6 months who apply to the Pediatric Outpatient Clinic of Kumluca State Hospital,
- Babies who do not have first degree diaper dermatitis according to the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants,
- Babies fed with breast milk + formula or only formula,
- Babies using antibiotics,
- Families who regularly use protective barrier cream/oil in diaper dermatitis care,
- Babies who switch to solid food,
- Babies with dermatological or other allergic skin problems,
- Babies using antimycotic drugs (Ampotericin etc.),
- Babies who use a bladder for a long time,
- Babies with urinary incontinence due to diseases such as meningomyolocele and cerebral palsy,
- Families who did not agree to participate in the research were not included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antalya Provincial Directorate of Health
Antalya, Kumluca/Antalya, 07000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ilknur Kahriman, Assoc. Prof.
Karadeniz Technical University
- PRINCIPAL INVESTIGATOR
Bahar Aksoy, MAster
Karadeniz Technical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof
Study Record Dates
First Submitted
November 7, 2023
First Posted
November 18, 2023
Study Start
December 24, 2022
Primary Completion
November 8, 2023
Study Completion
November 8, 2023
Last Updated
January 17, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 12 months after publication
- Access Criteria
- Relevance to the topic of the study and approval of all co-authors within 1 month of receiving the request.
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.